Company profile
Concarlo Therapeutics
Developing solutions for drug-resistant cancer
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- Brooklyn, New York
- Founded
- 2016
- LinkedIn followers
- 2,380
- Office locations
- 1
Concarlo Therapeutics company summary
Concarlo Therapeutics is a company in the Biotechnology Research industry, headquartered in Brooklyn, New York, founded in 2016. On LinkedIn the company has around 12 employees and 2,380 followers. Its listed specialties include Biotech, Drug development, Cancer Research, Breast Cancer, Drug-resistant Breast Cancer.
What technology does Concarlo Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Concarlo Therapeutics
Founded in July 2016 and headquartered in Brooklyn, New York, Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1. Concarlo's novel IpY therapeutic will be the first inhibitor to solve the CDK2 resistance issue, the first therapeutic to target p27 and the first to inhibit CDK4 and CDK2 simulataneously.
Specialties
Where is Concarlo Therapeutics located?
Concarlo Therapeutics lists 1 location.
Compare companies similar to Concarlo Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Concarlo Therapeutics concarlo.com | Biotechnology Research | 12 | 2016 | Brooklyn, New York |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Concarlo Therapeutics
What does Concarlo Therapeutics do?
Founded in July 2016 and headquartered in Brooklyn, New York, Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1. Concarlo's novel IpY therapeutic will be the first inhibitor to solve the CDK2 resistance issue, the first therapeutic to target p27 and the first to inhibit CDK4 and CDK2 simulataneously.
How many employees does Concarlo Therapeutics have?
Concarlo Therapeutics has around 12 employees on LinkedIn.
Where is Concarlo Therapeutics headquartered?
Concarlo Therapeutics is headquartered in Brooklyn, New York.
When was Concarlo Therapeutics founded?
Concarlo Therapeutics was founded in 2016.
Build a lead list from companies like Concarlo Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.